Synthesis and Characterization of a Lumacaftor-related Impurity: Aminomethyl Pyridinebenzoic Acid (AMPBA)
Lumacaftor (1, Figure 1) is a benzodioxole derivative used in combination with Ivacaftor in the treatment of cystic fibrosis in patients age 12 years and older.1-7 Lumacaftor is marketed under the ...
Authors
- M. Padma (ORCID: https://orcid.org/0000-0001-6213-1549)
- Srinu Karnati
- Abhishek Shankar Saxena
- Hanmanth Rao L (ORCID: https://orcid.org/0009-0008-1621-9214)
Institutions
- Andhra University (IN)
- Sugen Life Sciences (India) (IN)
Publication Details
- Journal
- Organic Preparations and Procedures International
- Published
- 2026-06-17
- DOI
- https://doi.org/10.1080/00304948.2026.2672751
- Primary Topic
- Cystic Fibrosis Research Advances
- Type
- article
- Field-Weighted Citation Impact
- 0.00